RN7SL280P

Across TCGA pan-cancer cohorts, RN7SL280P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RN7SL280P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RN7SL280P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL280P expression acts as an unfavorable survival marker, although some lineages such as LUAD and LAML show a favorable association.

LUSC, LUAD, and ACC are the cancer types where RN7SL280P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	III,IV	0.161	0.489	<.001	63	view →
LUAD	OS	Quartile	All	0.892	0.761	<.001	53	view →
ACC	OS	Tertile	All	0.484	0.831	.022	45	view →
THCA	OS	Quartile	All	0.945	0.983	.009	41	view →
KICH	OS	Tertile	III,IV	0.162	0.808	.001	36	view →
LAML	DFS	Tertile	All	0.696	0.383	.009	22	view →
UCS	OS	Tertile	IV	1.000	0.276	.018	18	view →
LIHC	DFS	Tertile	All	0.301	0.463	.019	15	view →
CESC	OS	Quartile	IV	0.307	0.623	.014	12	view →
PCPG	OS	Tertile	All	0.918	0.991	.016	12	view →
READ	DFS	Tertile	All	0.930	0.642	.037	12	view →
MESO	DFS	Tertile	IV	0.059	0.361	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RN7SL280P–LUSC (OS)

Open the LUSC breakdown →